Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non ‐small cell lung cancer
ConclusionSABR of 60 Gy in eight fractions is feasible for ultracentral NSCLC.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Dan Yang,
Jianing Cui,
Jun Zhao,
Jing You,
Rong Yu,
Huiming Yu,
Leilei Jiang,
Dongming Li,
Bo Xu,
Anhui Shi Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Esophagus Cancer | Heart | Lung Cancer | Non-Small Cell Lung Cancer | Toxicology